Taylorville Memorial Hospital Did Not Purchase Any Drugs from Massachusetts Pharmacy Suspected in Meningitis Outbreak
October 24, 2012
Taylorville Memorial Hospital did not purchase any drugs from a Massachusetts pharmaceutical company that is the focus of federal health officials investigating a fungal meningitis outbreak.
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are investigating a multistate fungal meningitis outbreak among patients who have received spinal injections of a steroid drug called methylprednisolone. An estimated 14,000 people received the injections of the contaminated steroid, which had been sent to 76 facilities in 23 states, according to the CDC. This form of meningitis is not contagious and is not spread from person to person.
“Taylorville Memorial Hospital did not purchase the contaminated steroid or any other drugs from the pharmacy, the New England Compounding Center in Framingham, Mass.,” said Dan Raab, president and chief executive officer of Taylorville Memorial Hospital.
Meningitis, an inflammation of the membranes surrounding the brain and spinal cord, is most often caused by viral infections but can be triggered by other sources, including fungi.
« View All News Stories